5-{2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one methanesulfonate (1:1)(CAS: 1308285-21-3)

This compound (CAS 1308285-21-3) is subject to various regulatory guidelines including GHS classification for hazard communication, REACH regulations in the EU for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA requirements for safe handling and disposal. Specific details on its health and environmental hazards must be obtained from the relevant regulatory bodies.

Alternatives to this compound in synthesis include structurally similar analogs or isomers, such as 5-{2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}-1-methyl-3-butyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one, which can serve as effective substitutes. Other reagents like amides or sulfoxides may also be considered as alternatives in some synthetic scenarios.

The market for this compound is driven by its applications in pharmaceuticals and research due to its biological activity. Research trends include exploring its potential in drug discovery for treating neurological disorders. Market trends show increasing demand in academic and industrial research settings, with price stability in the current market landscape.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method for disposal, while environmental protection precautions, such as neutralizing any acidic or basic compounds, should be taken to prevent environmental contamination. Compliance with local waste management regulations is essential.